quality of care

Clinical Pathways GPS

Hitting Each Component of the Triple Aim Along the Clinical Pathway

05/06/2016

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Scott Guerin, PhD

Seth Gordon, MBA

The concept of the Triple Aim—improving the experience of care, reducing the costs of care, and improving the health of populations—is increasingly becoming important to drug manufacturers, who must demonstrate how...

The...

05/06/2016

Journal of Clinical Pathways

Interview

An Alliance to Reform the Current Health Care System

05/06/2016

Enacted in March of 2010, the Affordable Care Act (ACA) aimed to provide Americans with better health security through comprehensive health insurance reforms.1 Since then, the ACA has helped to significantly reduce...

...

05/06/2016

Journal of Clinical Pathways

Research in Review

Elements for Successful Clinical Pathway Development and Maintenance Identified

05/06/2016

JCP Editors

As pathways become more ingrained in the everyday care of patients with various diseases, Andrew R Bunchert, MD, and Gabriella A Butler, MSN, RN, health care professionals at the Children’s Hospital of Pittsburgh...

As...

05/06/2016

Journal of Clinical Pathways

Research in Review

Clinical Pathways Improve Outcomes and Decrease Costs in Pediatric Care

05/06/2016

JCP Editors

The implementation of evidence-based, standardized clinical pathways may be an effective way of maintaining high-quality care at lower costs in pediatric care settings, results of a recent study show.  Clinical...

The...

05/06/2016

Journal of Clinical Pathways

Research in Review

05/06/2016

JCP Editors

A look at more than 10 years of data has shown that many patients with ovarian cancer covered by Medicare are not receiving treatment consistent with National Comprehensive Cancer Network (NCCN) recommendations,...

...

05/06/2016

Journal of Clinical Pathways

Same Survival and Toxicity With APBI and WBI for Breast Cancer

05/04/2016

JCP Editors

Accelerated partial breast irradiation (APBI) leads to the same rates of survival and toxicity as whole breast irradiation (WBI) while also producing significantly better cosmetic results, according to phase 3 trial...

...

05/04/2016

Journal of Clinical Pathways

Oncology Nurse Navigators Improve GI Cancer Outcomes

04/28/2016

JCP Editors

At the second annual Oncology Nurse Advisor Navigation Summit (April 7-9, 2016; Orlando, FL), Teresa Labovich, MSN, RN, OCN, Penrose Cancer Center (Colorado Springs, CO), described a method by which gastrointestinal...

At the...

04/28/2016

Journal of Clinical Pathways

Benefits of Using Comparative-Effectiveness Data in Lieu of Clinical Trials to Support Treatment Strategies

04/22/2016

JCP Editors

A lack of randomized controlled trials (RCTs) shouldn’t rule out the use of effective treatment strategies, such as stereotactic ablative radiotherapy (SABR), for lung cancer, urged a prominent oncologist recently....

A lack...

04/22/2016

Journal of Clinical Pathways

Research in Review

Stereotactic Body Radiation Therapy Results in Almost 100% Cure Rate For Patients With Prostate Cancer

04/22/2016

JCP Editors

A recent study showed a 98.6% cure rate at 5 years with stereotactic body radiation therapy (SBRT) in patients with low- or intermediate-risk prostate cancer. Current forms of radiation for prostate cancer are...

A...

04/22/2016

Journal of Clinical Pathways

Interview

Choosing Wisely: Addressing the Overuse of Medical Tests and Procedures

04/21/2016

JCP Editors

What methods are used to select the different recommendations that are endorsed by Choosing Wisely? What standard of evidence do you require to support these recommendations? Medical specialty societies develop...

What...

04/21/2016

Journal of Clinical Pathways